주메뉴 바로가기 본문 바로가기
KOR
KOR ENG

About F&T

메인으로 이동 About F&T Company Introduction
Company Introduction Vision CEO Message History Patents & Technology Key Partner Companies CI Directions

Company Introduction

A Future-Oriented Innovative Bio-Venture

Future & Tech is a pioneering bio-venture company that develops next-generation active immunotherapy treatments for various diseases that target humans and animals based on its proprietary GOST technology that induces active immune responses with self-proteins.

Since its inception in 2018 at the Jeonbuk Branch of the Korea Research Institute of Bioscience and Biotechnology, Future & Tech has focused on the research and development of innovative immune therapeutics, successfully delivering its proprietary GOST technology. GOST is a core technology that can be applied throughout the field of medicine, which addresses the high costs and side effects associated with monoclonal antibodies, an area in which major global pharmaceutical companies are highly engaged in. The breakthrough technology is expected to play a critical role in the development of new active immune drugs and technology for both human and veterinary use.

Core Technology

GOSTα (The 1st Tech. of Recombinant Bacteria Vaccine) Platform

  • G

    GRAS

  • O

    μ-Organism

  • S

    Surface-display

  • T

    Technique

(GRAS μ-Organism Surface-display Technique)
  • Special Point 01
    • Safety  : GRAS M/O, L. paracasei (Originated from Kimchi)
    • Efficacy  :  Easy culture & fast growth
  • Special Point 02
    • Safety  : Plasmid originated from L. plantarum
    • Efficacy  : Strong promoter in Lactic acid bacteria
  • Special Point 03
    • Safety  :  L. sakei origin lipoprotein
    • Efficacy  : Tight anchoring and stable overexpression on cell wall

Targeting a variety of targets

  • GDF-8
    (myostatin)
  • GDF-15
  • B7 - H1
    (PD-L1)
  • B7 - H3
    (CD276)
  • PCSK9
    CAP1
  • Autotaxin
  • Spike protein
    (RBD)
  • Muscular dystrophy
  • Sarcopenia
  • Chronic kidney disease
  • Type 2 diabetes
  • Cancer cachexia
  • Cancer immunotherapy
    (melanoma, prostate cancer)
  • Hypertension / Hyperlipidemia
  • Idiopathic pulmonary fibrosis
  • COVID prevention / treatment

GOST will play a crucial role in the development of new human and animal immune treatments and technology by targeting a wide range of diseases.

Cookie notice

By clicking 'Accept all cookies', you agree to the storing of cookies on your device and to the associated processing of data to enhance site navigation, analyse site usage, and assist in our marketing and performance efforts.

Cookie Consent Settings

  • Strictly Necessary Cookies always used
    This cookie is essential for the functionality of the site and is always used.
  • Functional Cookies
    These cookies are used for provide enhanced functionality and personalisation. You can turn these off but one or more of these services won't work properly.
    No cookies in use for this purpose
  • Marketing/Advertising Cookies
    These cookies are used to deliver adverts on third-party websites more relevant to you. You can turn these off but the third-party websites will show you less relevant adverts.
    No cookies in use for this purpose
  • Statistics Cookies
    These cookies are used to track your behaviours on our website and analyse them so we can provide better user experiences to you. You can turn these off.
    No cookies in use for this purpose
See details of the policy.